Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Income from Continuing Operations (2016 - 2025)

Lipocine's Income from Continuing Operations history spans 13 years, with the latest figure at 3186832.0 for Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 43.63% year-over-year to 3186832.0; the TTM value through Sep 2025 reached 5475238.0, down 34.99%, while the annual FY2024 figure was 8352.0, 100.05% up from the prior year.
  • Income from Continuing Operations reached 3186832.0 in Q3 2025 per LPCN's latest filing, down from 2205716.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 12624021.0 in Q4 2021 to a low of 6809041.0 in Q2 2021.
  • Average Income from Continuing Operations over 5 years is 1841799.26, with a median of 2631777.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: soared 379.83% in 2021, then tumbled 176.07% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 12624021.0 in 2021, then tumbled by 117.66% to 2229913.0 in 2022, then dropped by 2.35% to 2282253.0 in 2023, then soared by 178.09% to 1782183.0 in 2024, then plummeted by 278.82% to 3186832.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Income from Continuing Operations are 3186832.0 (Q3 2025), 2205716.0 (Q2 2025), and 1864873.0 (Q1 2025).